Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment
- PMID: 36612210
- PMCID: PMC9818548
- DOI: 10.3390/cancers15010215
Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment
Abstract
The three-dimensional architecture of genomes is complex. It is organized as fibers, loops, and domains that form high-order structures. By using different chromosome conformation techniques, the complex relationship between transcription and genome organization in the three-dimensional organization of genomes has been deciphered. Epigenetic changes, such as DNA methylation and histone modification, are the hallmark of cancers. Tumor initiation, progression, and metastasis are linked to these epigenetic modifications. Epigenetic inhibitors can reverse these altered modifications. A number of epigenetic inhibitors have been approved by FDA that target DNA methylation and histone modification. This review discusses the techniques involved in studying the three-dimensional organization of genomes, DNA methylation and histone modification, epigenetic deregulation in cancer, and epigenetic therapies targeting the tumor.
Keywords: DNA methylation; cancer; epigenetic inhibitors; epigenetics; histone modification.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.Clin Epigenetics. 2020 Oct 14;12(1):147. doi: 10.1186/s13148-020-00941-2. Clin Epigenetics. 2020. PMID: 33054831 Free PMC article. Review.
-
Understanding the consequences of epigenetic mechanisms and its effects on transcription in health and disease.Cancer Biol Ther. 2004 Sep;3(9):816-8. doi: 10.4161/cbt.3.9.1100. Epub 2004 Sep 23. Cancer Biol Ther. 2004. PMID: 15326369
-
Epigenomics in cancer management.Cancer Manag Res. 2010 Oct 27;2:255-65. doi: 10.2147/CMR.S7280. Cancer Manag Res. 2010. PMID: 21188117 Free PMC article.
-
Advances in Epigenetic Cancer Therapeutics.Cureus. 2020 Nov 27;12(11):e11725. doi: 10.7759/cureus.11725. Cureus. 2020. PMID: 33391954 Free PMC article. Review.
-
Effect of non-enzymatic glycosylation in the epigenetics of cancer.Semin Cancer Biol. 2022 Aug;83:543-555. doi: 10.1016/j.semcancer.2020.11.019. Epub 2020 Dec 2. Semin Cancer Biol. 2022. PMID: 33276090 Review.
Cited by
-
The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy.Cells. 2025 May 15;14(10):717. doi: 10.3390/cells14100717. Cells. 2025. PMID: 40422220 Free PMC article. Review.
-
An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherapy outcomes.Oncoimmunology. 2024 Jan 9;13(1):2303195. doi: 10.1080/2162402X.2024.2303195. eCollection 2024. Oncoimmunology. 2024. PMID: 38235318 Free PMC article.
-
H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications.Cancers (Basel). 2024 Oct 11;16(20):3451. doi: 10.3390/cancers16203451. Cancers (Basel). 2024. PMID: 39456545 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources